Author

V. Jenzelewski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:plant (other)· 1 Assay:protein structure· 1

Frequent Co-Authors

D. R. Drew· 2 shared D. Wetzel· 2 shared J.-A. Chan· 2 shared L. Reiling· 2 shared M. Piontek· 2 shared M. Suckow· 2 shared B. D. Wines· 1 shared B. Kouskousis· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. R. Drew

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel virus-like particle vaccine encoding the circumsporozoite protein of Plasmodium falciparum is immunogenic and induces functional antibody responses

L. Kurtovic, D. Wetzel, L. Reiling, D. R. Drew, C. Palmer, B. Kouskousis, E. Hanssen, B. D. Wines, P. M. Hogarth, M. Suckow, V. Jenzelewski, M. Piontek, J.-A. Chan, J. Beeson

This paper describes a novel virus-like particle vaccine using duck hepatitis B virus surface antigen to display Plasmodium falciparum CSP, showing improved immunogenicity and functional antibody responses in mice.

bioRxiv · Dec 14, 2020Immunology

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity

J.-A. Chan, D. Wetzel, L. Reiling, K. Miura, D. R. Drew, P. R. Gilson, D. A. Anderson, J. S. Richards, C. A. Long, M. Suckow, V. Jenzelewski, T. Tsuboi, M. J. Boyle, M. Piontek, J. G. Beeson

This study evaluates a novel virus-like particle platform for malaria vaccines, showing immunogenicity and transmission-blocking activity against Pfs230 and Pfs25 antigens.

bioRxiv · Aug 5, 2019Immunology